| Ms Karen Miller Pompi, RPH | |
|
66 Grand Blvd, Binghamton, NY 13905-3326 | |
| (607) 797-3449 | |
| Not Available |
| Full Name | Ms Karen Miller Pompi |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 66 Grand Blvd, Binghamton, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043584006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 025617 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karen Miller Pompi, RPH 66 Grand Blvd, Binghamton, NY 13905-3326 Ph: (607) 797-3449 | Ms Karen Miller Pompi, RPH 66 Grand Blvd, Binghamton, NY 13905-3326 Ph: (607) 797-3449 |
News Archive
The new health law's requirement that young adults be able to remain on their parents' health plans until they turn 26, is raising some questions from hopeful parents: "when exactly the new benefit begins, who exactly is eligible and who decides." But the answer to all those is: "It depends. ... the decision about when to start the new benefit is being made by lots of different players in the health system.
As part of its continuing effort to buttress food and medical product safety in this country by working with its regulatory partners overseas, the U.S. Food and Drug Administration today announced the opening of its Mexico City post. This is the Agency's third post in Latin America and its tenth international post in the past 13 months.
Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.
Two international charitable foundations, New Zealand-based Cure Kids and U.S.-based Children with Diabetes Foundation, have each pledged to provide US$140,000 to fund the final two patients in a Phase II clinical trial in New Zealand that has the potential to transform the treatment of Type 1 diabetes.
Vocal cord dysfunction (VCD) is the sudden, abnormal narrowing closure of the vocal cords during inhalation causing obstruction of the airflow, and is characterized by a noise that can mimic the sound of wheezing. A VCD attack can easily be mistaken for an asthma attack though it does not respond to asthma medications.
› Verified 5 days ago
Debra Knapp, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 Court St, Binghamton, NY 13901 Phone: 607-722-2351 Fax: 607-722-2380 | |
Benjamin H Fievisohn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 Robinson At, Rite Aid Pharmacy, Binghamton, NY 13901 Phone: 607-722-4221 | |
Allison Coughlin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 163 Robinson Street, Binghamton, NY 13904 Phone: 607-722-4976 | |
Meaghan Owen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 33 Mitchell Ave Ste 108, Binghamton, NY 13903 Phone: 607-352-5950 Fax: 607-352-5951 | |
Katie Cromer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Glenwood Ave, Binghamton, NY 13905 Phone: 607-770-1108 | |
Nicholas Joseph Bunts, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 Robinson St, Binghamton, NY 13904 Phone: 607-773-4352 |